Amgen announced that the results of two open-label extension (OLE) studies of AimovigTM (erenumab-aooe) in patients with chronic and episodic migraine, respectively, will be presented at the 60th Annual Scientific Meeting of the American Headache Society (AHS) in San Francisco. Results from a one-year study in chronic migraine patients reinforced the established safety and efficacy profile of Aimo...
Kratom shares structural similarities with opioid analgesics
Opioid-like dependence due to chronic kratom use can be successfully treated with buprenorphine, according to a recent case report published in the Journal of Addiction Medicine.
Kratom, an herbal supplement that shares structural similarities with opioid analgesics, has recently grown in popularity in the West ...
The US Food and Drug Administration (FDA) has approved updated labeling for Keytruda (pembrolizumab; Merck) and Tecentriq (atezolizumab; Genentech) for patients with locally advanced or metastatic urothelial cancer who are not eligible for cisplatin-containing chemotherapy.
The USFDA is continuing to review Merck's Keytruda and Roche's Tecentriq in pr...
Metformin found to help reverse lung fibrosis in mice
The type 2 diabetes drug metformin could be used to help treat lung fibrosis condition in the future, researchers have said.
Idiopathic pulmonary fibrosis (IPF) or lung fibrosis is a respiratory disease which occurs when scars are formed in the lung tissues, leading to breathing problems. It can develop after lung injuri...